| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/27/2023 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Common Stock | 25k | $0.00 | $0 | | 07/27/2023 |
| 07/27/2023 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Common Stock | 12.5k | $0.00 | $0 | | 07/27/2023 |
| 12/06/2022 | TherapeuticsMD, Inc. | TXMD | Sale | Common Stock | 440 | $4.92 | $2.2k | | 12/06/2022 |
| 12/06/2022 | TherapeuticsMD, Inc. | TXMD | Exercise | Restricted Stock Units | 1.7k | $0.00 | $0 | | 12/06/2022 |
| 03/23/2022 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 260k | $0.00 | $0 | | 03/23/2022 |
| 10/15/2021 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 260k | $0.00 | $0 | | 10/15/2021 |
| 10/15/2021 | TherapeuticsMD, Inc. | TXMD | Grant | Performance Stock Units | 260k | $0.00 | $0 | | 10/15/2021 |
| 10/15/2021 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 400k | $0.00 | $0 | | 10/15/2021 |
| 01/02/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 5.9k | $0.00 | $0 | | 01/02/2020 |
| 01/02/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy | 26.6k | $61.34 | $1.6M | | 01/02/2020 |
| 03/19/2018 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 5.7k | $1.70 | $9.7k | | 03/19/2018 |
| 05/11/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Common Shares, without par value | 80.2k | $0.00 | $0 | | 05/11/2017 |
| 05/11/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Employee Stock Option (right to buy) | 92.6k | $1.56 | $144.5k | | 05/11/2017 |
| 06/22/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Payment of Exercise | Common Shares, without par value | 10.8k | $3.34 | $36.1k | | 06/22/2016 |
| 05/16/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Purchase | Common Shares, without par value | 25k | $3.68 | $92k | | 05/16/2016 |
| 03/17/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Common Shares, without par value | 45.6k | $0.00 | $0 | | 03/17/2016 |
| 03/17/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Stock Options (right to buy) | 38.6k | $3.80 | $146.5k | | 03/17/2016 |
| 02/12/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Common Shares | 86.9k | $0.00 | $0 | | 02/12/2016 |
| 02/05/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Other (acquisition) | Common Shares | 29.1k | $0.00 | $0 | | 02/05/2016 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Restricted Stock Units (Performance Based) | 24k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Nonqualified Stock Option (Right to Buy) | 31.2k | $28.30 | $883k | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 704 | $28.30 | $19.9k | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 6.4k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/07/2013 |
| 02/07/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 2k | $23.68 | $47k | | 02/07/2014 |
| 02/03/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 388 | $24.70 | $9.6k | | 02/03/2014 |
| 02/07/2013 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Nonqualified Stock Option (Right to Buy) | 33k | $18.30 | $603.9k | | 02/07/2013 |
| 02/07/2013 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 426 | $18.30 | $7.8k | | 02/07/2013 |
| 02/07/2013 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 13.2k | $0.00 | $0 | | 02/07/2013 |
| 02/07/2013 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 3.9k | $0.00 | $0 | | 02/07/2013 |
| 02/07/2013 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 13.2k | $0.00 | $0 | | 02/07/2013 |